Selective Inhibition of Overactive Warmth-Sensitive Ca2+-permeable TRPV3 Channels by Antispasmodic Agent Flopropione for Alleviation of Skin Inflammation.

Yimei Xu,Yaxuan Qu,Congxiao Zhang,Canyang Niu,Xiaowen Tang,Xiaoying Sun,Kewei Wang

DOI: https://doi.org/10.1016/j.jbc.2023.105595

IF: 5.485

2024-01-01

Journal of Biological Chemistry

Abstract:The temperature-sensitive Ca2+-permeable TRPV3 ion channel is robustly expressed in the skin keratinocytes, and its gain-of-function mutations are involved in the pathology of skin lesions. Here, we report the identification of an antispasmodic agent flopropione that alleviates skin inflammation by selective inhibition of TRPV3. In whole-cell patch clamp recordings, flopropione selectively inhibits macroscopic TRPV3 currents in a concentration-dependent manner with an IC50 value of 17.8 +/- 3.5 mu M. At the single-channel level, flopropione inhibits TRPV3 channel open probability without alteration of its unitary conductance. In an in vivo mouse model of skin inflammation induced by the skin sensitizer DNFB, flopropione also alleviates dorsal skin lesions and ear skin swelling. Further molecular docking combined with site-directed mutagenesis reveals that two residues E501 and I505 in the channel S2-helix are critical for flopropione-mediated inhibition of TRPV3. Taken together, our findings demonstrate that the spasmolytic drug flopropione as a selective inhibitor of TRPV3 channel not only provides a valuable tool molecule for understanding of TRPV3 channel pharmacology but also holds repurposing potential for therapy of skin disorders, such as dermatitis and pruritus.